PharmacyInfoline.com

Charting India's Pharmaceutical Future at the 74th Indian Pharmaceutical Congress : Dr. Milind Umekar

Charting India's Pharmaceutical Future at the 74th IPC - Pharmacy Infoline 74th Indian Pharmaceutical Congress (IPC), hosted in Bengaluru by Association of Pharmaceutical Teachers of India (APTI) and the Indian Pharmaceutical Congress Association (IPCA), Maha-Kumbh" of Indian Pharmacy

All India Pharmaceutical Association Consortium Launches Programme to Empower MSMEs in Pharma Sector

All India Pharmaceutical Association Consortium Launches Programme to Empower MSMEs in Pharma Sector - Pharmacy Infoline AIPAC launches its first programme to empower MSMEs in the pharmaceutical sector, focusing on skill development, regulatory compliance, and scientific excellence.

Bio-Techne’s Asuragen Launches High-Sensitivity ESR1 Mutation Monitoring Assay for HR+ Metastatic Breast Cancer Research

Bio-Techne’s Asuragen Launches High-Sensitivity ESR1 Mutation Monitoring Assay for HR+ Metastatic Breast Cancer Research - Pharmacy Infoline Bio-Techne’s Asuragen launches a sensitive ESR1 mutation monitoring assay for HR+ metastatic breast cancer research, enhancing early detection of treatment resistance

Jupiter Foundation’s ‘My Organ Project’ raises awareness about organ donation, dispels myths, and encourages pledging organs to save lives, fostering a culture of giving in India

Jupiter Foundation Launches ‘My Organ Project’ to Promote Life-Saving Organ Donation Awareness - Pharmacy Infoline Jupiter Foundation’s ‘My Organ Project’ raises awareness about organ donation, dispels myths, and encourages pledging organs to save lives, fostering a culture of giving in India

FDA Recalls Duloxetine Antidepressant: Carcinogenic Impurities Found in 233,000+ Bottles
The U.S. Food and Drug Administration (FDA) has issued an urgent recall of over 233,003 bottles of duloxetine, a widely prescribed antidepressant, due to the detection of carcinogenic impurities. The recall, announced on November 19, 2024, highlights the presence of N-nitroso-duloxetine, a nitrosamine impurity exceeding the recommended safety limits.

FDA Recalls Duloxetine Antidepressant: Carcinogenic Impurities Found in 233,000+ Bottles - Pharmacy Infoline Rising Pharmaceuticals recalls over 233,000 bottles of duloxetine after FDA finds carcinogenic impurity N-nitroso-duloxetine above safe limits. Learn more about risks and alternatives.

Merck Announces Success of KEYLYNK-001 Trial in Ovarian Cancer Treatment



Merck, known as MSD outside the U.S. and Canada, has achieved a major milestone in cancer research. The pharmaceutical giant announced that its phase 3 KEYLYNK-001 trial has met the primary endpoint of progression-free survival (PFS) for patients with BRCA non-mutated advanced epithelial ovarian cancer. This breakthrough highlights the potential of combining Keytruda (pembrolizumab) and Lynparza (olaparib), with or without bevacizumab, as a first-line treatment.

Merck Announces Success of KEYLYNK-001 Trial in Ovarian Cancer Treatment - Pharmacy Infoline Merck’s KEYLYNK-001 trial demonstrates significant improvement in progression-free survival (PFS) for BRCA non-mutated advanced ovarian cancer using Keytruda and Lynparza. Explore findings and implications

Understanding S*x and Gender: A Complex Tapestry - Pharmacy Infoline Explore the concepts of s*x and gender, including biological s*x, gender identity, and gender expression. Understand how concepts intersect

Endometriosis: A Silent Struggle - Pharmacy Infoline Endometriosis, a chronic condition where tissue similar to the lining of the uterus grows outside the uterus, severe pain and infertility

Ozempic: A Closer Look at Potential Side Effects - Pharmacy Infoline Ozempic has gained popularity as a weight loss medication, but it's important to understand its potential side effects. common side effects

Mauna Kea Technologies Cellvizio: A Revolutionary Step in Medical Imaging - Pharmacy Infoline Mauna Kea Technologies Cellvizio: A Revolutionary Step in Medical Imaging Mauna Kea Technologies has revolutionized medical imaging with

Novavax: A Closer Look at the COVID-19 Vaccine - Pharmacy Infoline Explore the Novavax COVID-19 vaccine, a protein-based vaccine offering an alternative to mRNA and viral vector vaccines. efficacy, safety